Silo Pharma (SILO) Competitors $0.66 +0.04 (+6.57%) Closing price 10/15/2025 04:00 PM EasternExtended Trading$0.62 -0.04 (-5.45%) As of 07:48 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SILO vs. PMNT, EVKG, ONON, LULU, AS, GIL, LEVI, BIRK, KTB, and ZGNShould you be buying Silo Pharma stock or one of its competitors? The main competitors of Silo Pharma include Perfect Moment (PMNT), Ever-Glory International Group (EVKG), ON (ONON), lululemon athletica (LULU), Amer Sports (AS), Gildan Activewear (GIL), Levi Strauss & Co. (LEVI), Birkenstock (BIRK), Kontoor Brands (KTB), and Ermenegildo Zegna (ZGN). These companies are all part of the "apparel" industry. Silo Pharma vs. Its Competitors Perfect Moment Ever-Glory International Group ON lululemon athletica Amer Sports Gildan Activewear Levi Strauss & Co. Birkenstock Kontoor Brands Ermenegildo Zegna Silo Pharma (NASDAQ:SILO) and Perfect Moment (NASDAQ:PMNT) are both small-cap apparel companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, profitability, risk, media sentiment, earnings and institutional ownership. Is SILO or PMNT more profitable? Perfect Moment has a net margin of -67.38% compared to Silo Pharma's net margin of -6,798.61%. Silo Pharma's return on equity of -94.39% beat Perfect Moment's return on equity.Company Net Margins Return on Equity Return on Assets Silo Pharma-6,798.61% -94.39% -68.62% Perfect Moment -67.38%-513.83%-119.38% Do insiders & institutionals have more ownership in SILO or PMNT? 5.6% of Silo Pharma shares are owned by institutional investors. Comparatively, 23.0% of Perfect Moment shares are owned by institutional investors. 2.2% of Silo Pharma shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Does the media prefer SILO or PMNT? In the previous week, Silo Pharma had 1 more articles in the media than Perfect Moment. MarketBeat recorded 4 mentions for Silo Pharma and 3 mentions for Perfect Moment. Silo Pharma's average media sentiment score of 0.72 beat Perfect Moment's score of -0.09 indicating that Silo Pharma is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Silo Pharma 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Perfect Moment 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more risk & volatility, SILO or PMNT? Silo Pharma has a beta of 0.34, indicating that its stock price is 66% less volatile than the S&P 500. Comparatively, Perfect Moment has a beta of -3.36, indicating that its stock price is 436% less volatile than the S&P 500. Do analysts rate SILO or PMNT? Perfect Moment has a consensus price target of $1.50, indicating a potential upside of 209.60%. Given Perfect Moment's stronger consensus rating and higher probable upside, analysts clearly believe Perfect Moment is more favorable than Silo Pharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Silo Pharma 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00Perfect Moment 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has stronger earnings and valuation, SILO or PMNT? Silo Pharma has higher earnings, but lower revenue than Perfect Moment. Silo Pharma is trading at a lower price-to-earnings ratio than Perfect Moment, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSilo Pharma$70K98.62-$4.39M-$1.05-0.63Perfect Moment$22.00M0.77-$8.72M-$0.98-0.49 SummarySilo Pharma and Perfect Moment tied by winning 8 of the 16 factors compared between the two stocks. Get Silo Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for SILO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SILO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SILO vs. The Competition Export to ExcelMetricSilo PharmaMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.48M$3.36B$6.12B$10.45BDividend YieldN/A2.30%5.73%4.77%P/E Ratio-0.6322.7785.3327.36Price / Sales98.62486.46601.99136.95Price / CashN/A46.7037.4661.86Price / Book0.5910.5512.566.81Net Income-$4.39M-$52.58M$3.32B$276.80M7 Day Performance0.44%0.09%0.59%0.42%1 Month Performance-9.15%15.61%10.52%7.86%1 Year Performance-43.59%15.13%75.05%41.24% Silo Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SILOSilo Pharma0.7012 of 5 stars$0.66+6.6%N/A-41.1%$6.48M$70K-0.632Analyst ForecastGap DownPMNTPerfect Moment1.7403 of 5 stars$0.50-2.0%$1.50+198.8%-50.1%$17.62M$22.00M-0.3931News CoverageEVKGEver-Glory International GroupN/A$0.00flatN/AN/A$10KN/A0.004,300ONONON3.9348 of 5 stars$42.20-1.8%$63.65+50.8%-15.9%$27.06B$2.63B93.793,254Analyst DowngradeLULUlululemon athletica4.2446 of 5 stars$169.13-0.4%$232.29+37.3%-41.9%$20.14B$10.59B11.5039,000ASAmer Sports4.0127 of 5 stars$30.85-0.3%$43.49+40.9%+77.6%$17.14B$5.18B75.2613,400GILGildan Activewear4.1523 of 5 stars$60.69+0.3%$66.23+9.1%+27.0%$9.02B$3.27B19.2750,000News CoveragePositive NewsAnalyst ForecastLEVILevi Strauss & Co.4.7185 of 5 stars$21.34+0.8%$26.42+23.8%+10.8%$8.37B$6.36B14.0418,700Earnings ReportDividend AnnouncementAnalyst UpgradeAnalyst RevisionBIRKBirkenstock4.146 of 5 stars$42.66+0.2%$68.38+60.3%-15.7%$8.00B$2.03B23.707,400KTBKontoor Brands4.0501 of 5 stars$81.96+4.3%$91.86+12.1%+3.2%$4.37B$2.61B18.2913,200News CoverageAnalyst UpgradeZGNErmenegildo Zegna2.9466 of 5 stars$9.52+8.6%$10.43+9.7%+19.2%$3.57B$2.11B17.957,395Analyst UpgradeHigh Trading Volume Related Companies and Tools Related Companies Perfect Moment Competitors Ever-Glory International Group Competitors ON Competitors lululemon athletica Competitors Amer Sports Competitors Gildan Activewear Competitors Levi Strauss & Co. Competitors Birkenstock Competitors Kontoor Brands Competitors Ermenegildo Zegna Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SILO) was last updated on 10/16/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A Millionaire With SEVEN Clicks? $1,000 in just seven stocks in 2004 could have turned into a million-dolla...The Oxford Club | SponsoredShots officially fired…Elon Musk just declared war on the wireless giants with a $17 billion spectrum deal that gives SpaceX the righ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Silo Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Silo Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
